Figures & data
Figure 1. Comparison of the old (using conventional methods) and new (using WGS) diagnostic/surveillance strategies used in the Belgian NRC for M. tuberculosis complex. Turnaround time for the different steps is given. In case of urgent analysis, a GeneXpert® MTB/RIF assay can be performed
![Figure 1. Comparison of the old (using conventional methods) and new (using WGS) diagnostic/surveillance strategies used in the Belgian NRC for M. tuberculosis complex. Turnaround time for the different steps is given. In case of urgent analysis, a GeneXpert® MTB/RIF assay can be performed](/cms/asset/fc2afeb3-0bb9-439c-8672-5ef20f8669c1/yacb_a_1999588_f0001_oc.jpg)
Table 1. Description of the phenotypic and genotypic drug resistance profiles obtained on the M. tuberculosis complex strains analysed in 2019 at the Belgian National Reference Center
Table 2. Performance of whole-genome sequencing compared to phenotypic drug susceptibility testing (MGIT) for first-line drugs on the M. tuberculosis complex strains analysed in 2019 at the Belgian National Reference Center